DENTSPLY SIRONA (XRAY) has initiated a process to evaluate strategic alternatives for its Wellspect Healthcare business. Wellspect is a leading ...

Dentsply Sirona announced that it initiated a process to evaluate strategic alternatives for its Wellspect Healthcare ...

Dentsply Sirona initiated a process to evaluate strategic alternatives for its Wellspect Healthcare business. Wellspect, a provider of bladder and bowel management care products, has an estimated $2 ...

Extends Private Placement and Grants Stock Options Toronto, Ontario--(Newsfile Corp. - February 12, 2025) - City View Green ...

Veradigm® (OTCMKTS: MDRX), a leading provider of healthcare data and technology solutions, announced today that the Veradigm Board of Directors (the “ ...

FORT WORTH, Texas - PharmChem, Inc. (OTC: PCHM), known for its drug-detecting sweat patches and currently trading at $3.07 near its 52-week low, announced Monday that its Board of Directors is ...

23andMe Holding Co. ( ME, Financials) announced that its board's Special Committee is reviewing strategic alternatives, including a potential sale, business combination, asset sales, restructuring, or ...

23andMe said it's started exploring strategic alternatives, including a possible sale. The company released third-quarter ...

The company's management and Board of Directors are now exploring strategic alternatives to maximize shareholder value, which may include potential acquisitions or business combinations.

CHARLOTTE, N.C., Feb. 11, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that the Company has initiated a process to evaluate ...

23andMe said it's started exploring strategic alternatives, including a possible sale. The company released third-quarter results that showed an 8% drop in consumer services revenue year over year.